These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25755184)

  • 1. Cardiomyopathy in Marfan syndrome.
    Hetzer R; Siegel G; Delmo Walter EM
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):561-7; discussion 567-8. PubMed ID: 25755184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orthotopic heart transplantation in patients with Marfan syndrome.
    Knosalla C; Weng YG; Hammerschmidt R; Pasic M; Schmitt-Knosalla I; Grauhan O; Dandel M; Lehmkuhl HB; Hetzer R
    Ann Thorac Surg; 2007 May; 83(5):1691-5. PubMed ID: 17462381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three decades of heart transplantation in Scandinavia: long-term follow-up.
    Dellgren G; Geiran O; Lemström K; Gustafsson F; Eiskjaer H; Koul B; Hagerman I; Selimovic N;
    Eur J Heart Fail; 2013 Mar; 15(3):308-15. PubMed ID: 23109651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome?
    Massad MG; McCarthy PM; Smedira NG; Cook DJ; Ratliff NB; Goormastic M; Vargo RL; Navia J; Young JB; Stewart RW
    J Thorac Cardiovasc Surg; 1996 Nov; 112(5):1275-81; discussion 1282-3. PubMed ID: 8911324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restrictive mitral annuloplasty with or without surgical ventricular reconstruction in ischaemic cardiomyopathy: impacts on neurohormonal activation, reverse left ventricular remodelling and survival.
    Kainuma S; Taniguchi K; Toda K; Funatsu T; Miyagawa S; Kondoh H; Masai T; Otake S; Yoshikawa Y; Nishi H; Sakaguchi T; Ueno T; Kuratani T; Daimon T; Sawa Y
    Eur J Heart Fail; 2014 Feb; 16(2):189-200. PubMed ID: 24464828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.
    De Backer J
    Verh K Acad Geneeskd Belg; 2009; 71(6):335-71. PubMed ID: 20232788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased need for right ventricular support in patients with chemotherapy-induced cardiomyopathy undergoing mechanical circulatory support: outcomes from the INTERMACS Registry (Interagency Registry for Mechanically Assisted Circulatory Support).
    Oliveira GH; Dupont M; Naftel D; Myers SL; Yuan Y; Tang WH; Gonzalez-Stawinski G; Young JB; Taylor DO; Starling RC
    J Am Coll Cardiol; 2014 Jan; 63(3):240-8. PubMed ID: 24161324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome after redo coronary artery bypass grafting in patients with ischaemic cardiomyopathy and viable myocardium.
    Rizzello V; Poldermans D; Schinkel AF; Biagini E; Boersma E; Elhendy A; Sozzi FB; Palazzuoli A; Maat A; Crea F; Bax JJ
    Heart; 2007 Feb; 93(2):221-5. PubMed ID: 16905627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nontransplant cardiac surgery for end-stage cardiomyopathy.
    Suma H; Isomura T; Horii T; Sato T; Kikuchi N; Iwahashi K; Hosokawa J
    J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1233-44. PubMed ID: 10838543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for Marfan cardiomyopathy.
    Alpendurada F; Wong J; Kiotsekoglou A; Banya W; Child A; Prasad SK; Pennell DJ; Mohiaddin RH
    Eur J Heart Fail; 2010 Oct; 12(10):1085-91. PubMed ID: 20861133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting.
    Gioia G; Matthai W; Gillin K; Dralle J; Benassi A; Gioia MF; White J
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):26-33. PubMed ID: 17585381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy.
    Hetzer R; Müller JH; Weng YG; Loebe M; Wallukat G
    J Thorac Cardiovasc Surg; 2000 Nov; 120(5):843-53. PubMed ID: 11044309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac transplantation for radiation-induced cardiomyopathy: the Mayo Clinic experience.
    Saxena P; Joyce LD; Daly RC; Kushwaha SS; Schirger JA; Rosedahl J; Dearani JA; Kara T; Edwards BS
    Ann Thorac Surg; 2014 Dec; 98(6):2115-21. PubMed ID: 25443015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of mitral insufficiency on reoperative coronary artery surgery in ischemic cardiomyopathy patients.
    Wang N; Campwala S; Habibipour S; Hodgins D; Pai R; Razzouk A
    Eur J Cardiothorac Surg; 2004 Dec; 26(6):1118-28. PubMed ID: 15541972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.
    Bull DA; Reid BB; Selzman CH; Mesley R; Drakos S; Clayson S; Stoddard G; Gilbert E; Stehlik J; Bader F; Kfoury A; Budge D; Eckels DD; Fuller A; Renlund D; Patel AN
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):169-73. PubMed ID: 20451930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting long-term functional results after myocardial revascularization in ischemic cardiomyopathy.
    Luciani GB; Montalbano G; Casali G; Mazzucco A
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):478-89. PubMed ID: 10962408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of mitral regurgitation in Marfan syndrome: Outcomes of valve repair versus replacement and comparison with myxomatous mitral valve disease.
    Helder MR; Schaff HV; Dearani JA; Li Z; Stulak JM; Suri RM; Connolly HM
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1020-4; discussion 1024. PubMed ID: 25129593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft coronary artery disease is strongly related to the aetiology of heart failure and cellular rejections.
    Lindelöw B; Bergh C; Lamm C; Andersson B; Waagstein F
    Eur Heart J; 1999 Sep; 20(18):1326-34. PubMed ID: 10462467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic cardiomyopathy is associated with coronary plaque progression and higher event rate in patients after cardiac transplantation.
    Guddeti RR; Matsuo Y; Matsuzawa Y; Aoki T; Lennon RJ; Lerman LO; Kushwaha SS; Lerman A
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25095871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.